Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risk assessment in clinical pharmacy.

Patrick T Hudson1, Henk-Jan Guchelaar

  • 1Centre for Safety Science, Department of Psychology, Faculty of Social Sciences, Leiden University, Leiden, The Netherlands. hudson@fsw.leidenuniv.nl

Pharmacy World & Science : PWS
|July 5, 2003
PubMed
Summary

Medication errors are common, but systematic safety assessments are lacking in pharmacy. This study proposes a novel risk assessment framework to proactively identify and measure safety barriers, enhancing pharmaceutical system safety and audit standards.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Impact of UGT1A1 Genotype-Guided Irinotecan Dosing on Severe Toxicity and Hospitalization: A Multicenter Study.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A <i>DPYD</i> Variant Allele.

JCO precision oncology·2026
Same author

Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumab.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Correction: Model‑Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness.

Clinical pharmacokinetics·2026
Same author

Predictors of poor treatment tolerability in older patients receiving fluoropyrimidine-based chemotherapy: A prospective cohort study.

Journal of geriatric oncology·2026
Same author

Correction: Model‑Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness.

Clinical pharmacokinetics·2026

Area of Science:

  • Pharmacy
  • Healthcare Safety
  • Risk Management

Background:

  • Medication errors constitute a significant portion of medical system errors.
  • Current approaches to pharmaceutical safety primarily rely on reactive incident analysis rather than proactive risk assessment.
  • Systematic methods for ensuring and assessing the safety of pharmaceutical systems are underdeveloped.

Purpose of the Study:

  • To propose a structured risk assessment framework specifically for pharmacy processes.
  • To provide a systematic method for identifying and evaluating safety defenses within pharmaceutical systems.
  • To establish a standard for auditing pharmaceutical safety and supporting incident investigations.

Main Methods:

  • Adapting risk assessment methodologies commonly used in hazardous industries (e.g., nuclear power, oil and gas).

Related Experiment Videos

  • Identifying potential risk factors that can degrade safety barriers in pharmacy.
  • Developing a framework to measure the effectiveness of identified defenses.
  • Proposing a structure applicable to both proactive risk assessment and reactive incident analysis.

    • Main Results:

    • A novel risk assessment structure for pharmacy processes has been developed.
    • The proposed structure allows for the identification and measurement of safety barriers and risk factors.
    • The framework can be utilized for proactive safety evaluation and reactive incident analysis.
    • It offers a standardized approach for auditing pharmaceutical safety.

    Conclusions:

    • The proposed risk assessment structure offers a systematic and proactive approach to enhancing pharmaceutical safety.
    • This framework moves beyond reactive incident analysis, providing tools for continuous safety improvement.
    • Implementation of this structure can lead to more robust safety standards and effective audits in clinical pharmacy.